India Globalization rises on deal for potential Alzheimer's treatment

IGC Pharma

21/06/2022 12:05

** Drugmaker India Globalization Capital Inc's shares
 IGC.A  rise 13.7% to $0.66 premarket
    ** Co's subsidiary enters into intellectual property license
agreement for a potential Alzheimer's drug candidate
 urn:newsml:reuters.com:*:nFWN2Y709X
    ** The compound, TGR 63, identified by researchers at
Jawaharlal Nehru Centre for Advanced Scientific Research
    ** IGC acquires exclusive global rights to TGR 63 and plans
to develop it further
    ** IGC down ~41% YTD as of last close

 (Reporting by Mrinalika Roy in Bengaluru)
 ((mrinalika.roy@thomsonreuters.com; within U.S. +1 646 223
8780, outside U.S. +91 806749 8325;))